ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Using eConsent Data To Populate Site And Sponsor Data Systems

  A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.

• From Frustration To Organization: An SSO Platform For Trial Sites

  To reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.

• What Does EDC Look Like In 2024 And Beyond?

  Read along as industry experts from TrialKit offer insights into the anticipated developments and challenges surrounding electronic data capture.

• Accelerating Your New Therapies Path To Market With Automation

  Automation has become an essential tool for addressing the inefficiencies in traditional clinical trial methodologies, enabling trial teams to instead concentrate on critical tasks such as patient care.

• A Data-Driven Approach To Clinical Trial Site Selection

  By incorporating data-driven site selection and verification, sponsors can optimize resource allocation, enhance protocol compliance, and improve overall trial integrity.

• Navigating eCOA Licensing And Localization In Clinical Trials

  eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.

• Commercializing Rare Disease Treatment With Near Real-Time Alerts

  How did Quest help a leading pharmaceutical company overcome the data latency challenges associated with traditional EHR when recruiting eligible patients for a rare blood disorder drug?

• Mitigating Study Risk With Performance Analytics

  Performance metrics for supporting risk-based management can be great, however, this author tells readers why collecting and analyzing data after a study has begun may not be the best approach.

• Beyond The Pandemic: Why eCOAs Are Here To Stay

  The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.

• Introducing Digitally-Enabled Biosample Consent Storage

  Despite the rise of digital solutions in healthcare, paper consent forms are still common in today’s clinical trials. Unfortunately, these paper forms pose significant challenges in retaining the documentation of informed consent for centrally stored biospecimens.